Canaccord Genuity Maintains a 'Hold' on AngioDynamics (ANGO); FDA Warns ANGO on Off-Label Promotion of NanoKinfe
Tweet Send to a Friend
Canaccord Genuity maintains a 'Hold' on AngioDynamics (NASDAQ: ANGO), PT $17.
Canaccord analyst says, "We do not believe the recently-announced ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord analyst says, "We do not believe the recently-announced ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
